Prospects of Non-Coding Elements in Genomic DNA Based Gene Therapy
S P Simna1, Zongchao Han1,2,3
1Department of Ophthalmology, the University of North Carolina at Chapel Hill, Chapel Hill, NC27599, USA.
Abstract:
Gene therapy has made significant development since the commencement of the first clinical trials a few decades ago and has remained a dynamic area of research regardless of obstacles such as immune response and insertional mutagenesis. Progression in various technologies like next-generation sequencing (NGS) and nanotechnology has established the importance of non-- coding segments of a genome, thereby taking gene therapy to the next level. In this review, we have summarized the importance of non-coding elements, highlighting the advantages of using full- length genomic DNA loci (gDNA) compared to complementary DNA (cDNA) or minigene, currently used in gene therapy. The focus of this review is to provide an overview of the advances and the future of potential use of gDNA loci in gene therapy, expanding the therapeutic repertoire in molecular medicine.
More Related Videos
08:15gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair
Published on: October 6, 2014
11:58Linear Amplification Mediated PCR – Localization of Genetic Elements and Characterization of Unknown Flanking DNA
Published on: June 25, 2014
Related Concept Videos
Gene Therapy
Microorganisms in Medicine and Therapeutics
Organization of Genes
CRISPR
What is Genetic Engineering?
DNA-only Transposons
The donor site from where the transposon is excised is either degraded or...
